Clinical management of Staphylococcus aureus bacteraemia.
Staphylococcus aureus bacteraemia is one of the most common serious bacterial infections worldwide. In the UK alone, around 12,500 cases each year are reported, with an associated mortality of about 30%, yet the evidence guiding optimum management is poor. To date, fewer than 1500 patients with S au...
Main Authors: | Thwaites, G, Edgeworth, J, Gkrania-Klotsas, E, Kirby, A, Tilley, R, Török, M, Walker, S, Wertheim, H, Wilson, P, Llewelyn, M |
---|---|
Format: | Journal article |
Sprog: | English |
Udgivet: |
2011
|
Lignende værker
-
Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: observational analyses within the ARREST trial
af: Szubert, AJ, et al.
Udgivet: (2019) -
Clinical and Microbiological Determinants of Outcome in
Staphylococcus aureus Bacteraemia
af: James Price, et al.
Udgivet: (2010-01-01) -
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
af: Thwaites, G, et al.
Udgivet: (2012) -
Clinical sub-phenotypes of Staphylococcus aureus bacteraemia
af: Swets, MC, et al.
Udgivet: (2024) -
Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial
af: Thwaites Guy, et al.
Udgivet: (2012-12-01)